Dong Sung Bio Pharm.Co.,Ltd. (KOSE: A002210)
Health Care · Pharmaceuticals · KR
₩1,495.00
-11.43% today · -16.9% 1Y
Dong Sung Bio Pharm.Co.,Ltd. (KOSE: A002210) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $101.28M.
Over the last twelve months the share price has lost 16.9%, trading between 1.48K and 2.52K.
Tweenvest scores Dong Sung Bio Pharm.Co.,Ltd. across four factors: quality 56/100, value 62/100. Its strongest factor is value.
A002210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $101.28M
- Revenue (TTM)
- $67.58M
- P/E
- 15.52
- EPS
- 96.34
- Dividend yield
- —
- Beta (5Y)
- -0.37
- 52-week high
- ₩2,525.00
- 52-week low
- ₩1,480.00
- Avg volume (3M)
- —
- Shares outstanding
- 93.88M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.